LITU chairman Ganpati Yadav to get ‘Paryavaran Bhushan' Award
2
3
Nagpur: Eminent chemical engineering scientist Professor Ganapati D Yadav, Laxminarayan Innovation Technological University (LITU) Board of Governnance (BOG) chairman and former vice-chancellor of the Institute of Chemical Technology (ICT), Mumbai, and currently National Science Chair of the Govt of India, has been selected for the prestigious 'Paryavaran Bhushan' Award.
The award will be jointly conferred by the Maharashtra Pollution Control Board (MPCB) and the Environmental Club of India in July 2025.
Prof Yadav, who also holds the esteemed position of Bhatnagar Fellow, the highest honour of the Council of Scientific and Industrial Research (CSIR), is widely acclaimed for his pioneering contributions in the areas of green hydrogen, circular economy, and carbon dioxide valorisation — key domains driving the global pursuit of net-negative energy transition and sustainable development.
With over 150 national and international accolades, awards, fellowships, and distinctions, Prof Yadav is one of the most decorated engineering scientists in India. His groundbreaking research continues to inspire innovation and policy in environmental protection and green energy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
18-07-2025
- Time of India
LIT University invites applications for specialised postgraduate programmes
Nagpur: The Laxminarayan Innovation Technological University (LITU), formerly the Laxminarayan Institute of Technology, has announced admissions open for its specialised postgraduate programmes for the academic session 2025-26. Accredited with NAAC A+ (CGPA 3.48), the university offers advanced MTech programmes in chemical engineering, food technology, petrochemical technology, surface coating, oil technology, and polymers. It also offers MSc courses in microbiology, biotechnology, and biochemistry. Notably, the MTech in chemical engineering and paint technology achieved 100% placement last year, and MSc graduates secured jobs in core domain companies, highlighting the industry relevance of these programmes. LIT boasts of NBA-accredited undergraduate programmes in chemical engineering and petrochemical technology, reinforcing its academic excellence. The Rajiv Gandhi Biotechnology Centre, established in 1995, continues to drive impactful research and innovation in microbial biotechnology across Vidarbha. This year, the department of microbiology marks 50 years of academic contribution, while the biochemistry department, founded in 1946, offers students hands-on learning through its clinical diagnostic laboratory. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like An engineer reveals: One simple trick to get internet without a subscription Techno Mag Learn More Undo With a legacy of producing leaders in academia and industry, LIT University invites ambitious students to be part of its growing legacy. For admission queries, students may contact: Dr Bharat Bhanvase (MTech): 9850637449, Dr Arti Shanware (Biotechnology): 9823018963, Dr Pradeep Tumane (Microbiology): 9850349985, Dr Arti Moon (Biochemistry): 77987 44244, Dr Saurabh Joglekar (PRO): 9766366961 or visit:
Time of India
10-07-2025
- Time of India
LITU scholar Neha Thakare gets first prize in SOMS-2025
1 2 3 4 5 Nagpur: Neha Thakare a PhD scholar of chemical engineering department of Laxminarayan Innovation Technological University (LITU), won first prize at national-level competition held during SOMS-2025 in Gandhinagar, Gujarat. The July 3-5 event was jointly organised by Soluble Fertilizer Industry Association (SFIA) and the ICAR-National Research Centre for Grapes (ICAR-NRC Grapes), Pune. Neha worked under the guidance of Dr Bharat Bhanvase. She was the only scholar shortlisted from the Maharashtra and presented her innovative research on 'Advanced oxidation process for ammonia recovery from wastewater and reuse as a soluble fertilizer." Her work introduces a pioneering approach using hydrodynamic cavitation and advanced oxidation to convert wastewater pollutants into valuable agricultural inputs — an innovation praised for its environmental significance and industrial relevance. LITU vice-chancellor Dr Atul Vaidya congratulated Neha and Dr Bhanvase, stating, "The outstanding achievement is a proud moment for LITU. Neha's research not only reflects our academic excellence but also contributes meaningfully to the national dialogue on sustainable agriculture and wastewater valorisation."
Mint
04-07-2025
- Mint
AIIMS says no link between covid jabs and sudden deaths among young adults
Doctors at Delhi's All India Institute of Medical Sciences (AIIMS-Delhi) have refuted claims linking Covid-19 vaccines to sudden deaths in young adults in the country. This comes in the backdrop of recent claims by Karnataka Chief Minister Siddaramaiah stating that covid vaccines were linked to sudden deaths due to cardiac arrest among young adults in the state's Hassan district. The country's premier medical institution announced that its studies have found no such connection, instead attributing these tragic incidents primarily to lifestyle factors such as smoking, high blood pressure, and stress. Senior AIIMS doctors emphasized the crucial role these vaccines played in saving lives during the pandemic, noting that the studies are ongoing to determine the causes of sudden unexplained deaths. Researchers at AIIMS's pathology department are currently undertaking genomic studies to find the unexplained causes of death in approximately 25% of cases involving young individuals, where no apparent cause was initially identified. The pharmaceutical industry has also vouched for vaccine safety and debunked doubts over efficacy. Dr. Abhishek Yadav, additional professor in the department of forensic medicine at AIIMS, detailed two studies conducted by his department. A retrospective analysis from 2018 to 2022, comparing pre- and post-Covid data, found "no surge in the sudden cardiac deaths in the cases which were reported in the department". A second, ongoing study, initiated in 2023 in collaboration with the Indian Council of Medical Research (ICMR) and slated to continue for another year and a half, aims to gather more samples for scientifically validated results. This study has so far examined approximately 230 death cases, collecting family history, performing genomic and DNA level studies, and utilizing virtual autopsies. Dr. Yadav stated that this second study has also 'not found any link between covid vaccine and sudden deaths.' The research categorized cases into two age groups: 18-45 years and 45-65 years. Dr. Yadav said that coronary artery disease was identified as the most common historical factor, with over 50% of these cases linked to lifestyle factors and substance abuse, such as alcohol and smoking. The pathology department of AIIMS is continuing genomic studies on the remaining 25% of unexplained cases. Dr. Sudheer Arava, a professor in the department of pathology at AIIMS, explained that the study of 230 young individuals brought to the forensic department found heart attack to be the most common cause of death (50%), often linked to lifestyle risk indicators like high blood pressure, cholesterol, stress, and obesity. 'In 25% of cases, no identifiable cause of death was determined, and researchers are exploring potential molecular alterations. An interim report submitted to the ICMR indicates that nearly 50% of the deaths studied were due to heart attacks, with further research ongoing.' Dr. Sanjay Rai, professor at the department of community medicine at AIIMS, stated that the Covishield vaccine (developed by Oxford–AstraZeneca) showed an efficacy of 62.1%. He highlighted that various regulatory authorities have approved 37 different Covid-19 vaccines, with the World Health Organization (WHO) approving approximately 12, utilizing diverse technologies. For instance, Bharat Biotech's Covaxin uses a traditional technology, while Covishield and Russian Sputnik V are based on an adenovirus vector. Globally, over 13 billion vaccine doses have been administered, with countries like the United States completing fourth doses. The WHO now recommends vaccination for everyone aged six months and above, particularly with vaccines effective against newer variants. Dr. Karan Madan, associate professor in the department of pulmonary medicine, affirmed that Covid-19 vaccines were "highly effective and instrumental in lowering mortality rates during the pandemic". He emphasized their role as the "sole possible measure to save lives" at the time, providing "immense advantages" in preventing excess deaths. Dr. Madan also referenced a study on sudden cardiac deaths that found "no clear association" with vaccine usage. Sudarshan Jain, secretary general of the Indian Pharmaceutical Alliance (IPA), underscored India's role as a knowledge-driven sector, accounting for 60% of global vaccine production. He stated that Covid vaccines were "well documented and rigorously tested as per regulatory processes," warning that "misinformation and distortion of facts endanger public health and undermine the trust built on science and patient care globally". The Indian Vaccine Manufacturers Association also said that all Covid-19 vaccines in India received Emergency Use Authorization based on extensive preclinical and human clinical trial evaluations, showing positive results for safety, efficacy, and immunogenicity. Covid infections have been on a declining trend after showing a steady increase in the past few weeks. On Thursday, the country's active caseload dropped to 1,290 from 1,691 cases, with no deaths reported in the last 24 hours. The total number of Covid-19-related deaths this year stands at 146. The current spread is linked to Omicron sub-variants NB.1.8.1 and LF.7.
